-
Something wrong with this record ?
Regio- and Stereoselective Synthesis of Nitro-fatty Acids as NRF2 Pathway Activators Working under Ambient or Hypoxic Conditions
D. Chrenko, J. Pereckova, M. Zatloukalová, J. Vacek, J. Pospíšil, T. Perecko
Language English Country United States
Document type Journal Article
- MeSH
- Nitro Compounds * pharmacology chemical synthesis chemistry MeSH
- NF-E2-Related Factor 2 * metabolism MeSH
- Heme Oxygenase-1 metabolism MeSH
- Cell Hypoxia MeSH
- Linoleic Acids chemical synthesis chemistry pharmacology MeSH
- Oxygen metabolism MeSH
- Fatty Acids * pharmacology chemical synthesis chemistry MeSH
- Mice MeSH
- Signal Transduction drug effects MeSH
- Stereoisomerism MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Nitro-fatty acids (NO2FAs) are endogenously produced electrophiles and NRF2 activators with therapeutic potential. We developed a synthetic protocol combining a Henry reaction and base-promoted β-elimination, yielding ultrapure regio/stereoisomers of nitro-stearic (NO2SA), nitro-oleic (NO2OA), and conjugated/bis-allylic nitro-linoleic (NO2LA) acids. These were tested for NRF2 pathway activation in bone marrow cells under different oxygen conditions. We observed that 9- and 10-NO2OA, and 10-NO2LA increased NRF2 stabilization under hypoxia, while 9- and 10-NO2OA significantly upregulated Hmox1 and Gclm at all oxygen levels. 9- and 10-NO2OA enhanced HO-1 and GCLM proteins independently of oxygen, while 10-NO2LA was oxygen-dependent, boosting HO-1 under hypoxia and GCLM under ambient conditions. Moreover, 10-NO2OA and 10-NO2LA induced NRF2 nuclear translocation. In contrast, the saturated 10-NO2SA, which has lower electron-acceptor ability, was inactive. In summary, these findings suggest the biological activity of NO2FAs is dependent on oxygen level, which could be used in future research of other oxidative stress-dependent pathways.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25015324
- 003
- CZ-PrNML
- 005
- 20250731090919.0
- 007
- ta
- 008
- 250708s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.jmedchem.5c00982 $2 doi
- 035 __
- $a (PubMed)40419458
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Chrenko, Daniel $u Department of Chemical Biology, Faculty of Science, Palacky University, Šlechtitelů 27, CZ-783 71 Olomouc, Czech Republic $1 https://orcid.org/0000000259265324
- 245 10
- $a Regio- and Stereoselective Synthesis of Nitro-fatty Acids as NRF2 Pathway Activators Working under Ambient or Hypoxic Conditions / $c D. Chrenko, J. Pereckova, M. Zatloukalová, J. Vacek, J. Pospíšil, T. Perecko
- 520 9_
- $a Nitro-fatty acids (NO2FAs) are endogenously produced electrophiles and NRF2 activators with therapeutic potential. We developed a synthetic protocol combining a Henry reaction and base-promoted β-elimination, yielding ultrapure regio/stereoisomers of nitro-stearic (NO2SA), nitro-oleic (NO2OA), and conjugated/bis-allylic nitro-linoleic (NO2LA) acids. These were tested for NRF2 pathway activation in bone marrow cells under different oxygen conditions. We observed that 9- and 10-NO2OA, and 10-NO2LA increased NRF2 stabilization under hypoxia, while 9- and 10-NO2OA significantly upregulated Hmox1 and Gclm at all oxygen levels. 9- and 10-NO2OA enhanced HO-1 and GCLM proteins independently of oxygen, while 10-NO2LA was oxygen-dependent, boosting HO-1 under hypoxia and GCLM under ambient conditions. Moreover, 10-NO2OA and 10-NO2LA induced NRF2 nuclear translocation. In contrast, the saturated 10-NO2SA, which has lower electron-acceptor ability, was inactive. In summary, these findings suggest the biological activity of NO2FAs is dependent on oxygen level, which could be used in future research of other oxidative stress-dependent pathways.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a hypoxie buňky $7 D015687
- 650 12
- $a mastné kyseliny $x farmakologie $x chemická syntéza $x chemie $7 D005227
- 650 _2
- $a hemoxygenasa-1 $x metabolismus $7 D051547
- 650 12
- $a faktor 2 související s NF-E2 $x metabolismus $7 D051267
- 650 12
- $a dusíkaté sloučeniny $x farmakologie $x chemická syntéza $x chemie $7 D009574
- 650 _2
- $a kyslík $x metabolismus $7 D010100
- 650 _2
- $a signální transdukce $x účinky léků $7 D015398
- 650 _2
- $a stereoizomerie $7 D013237
- 650 _2
- $a kyseliny linolové $x chemická syntéza $x chemie $x farmakologie $7 D008041
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pereckova, Jana $u Department of Cell Biology and Radiobiology, Institute of Biophysics of the Czech Academy of Sciences, Kralovopolska 135, 612 00 Brno, Czech Republic $1 https://orcid.org/000000027565993X
- 700 1_
- $a Zatloukalová, Martina $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University, Hnevotinska 3, 775 15 Olomouc, Czech Republic
- 700 1_
- $a Vacek, Jan $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University, Hnevotinska 3, 775 15 Olomouc, Czech Republic $1 https://orcid.org/000000015490082X $7 xx0104698
- 700 1_
- $a Pospíšil, Jiří $u Department of Chemical Biology, Faculty of Science, Palacky University, Šlechtitelů 27, CZ-783 71 Olomouc, Czech Republic $u Department of Organic Chemistry, Faculty of Science, Palacky University, tř. 17. listopadu 1192/12, CZ-771 46 Olomouc, Czech Republic $u Laboratory of Growth Regulators, Palacky University & Institute of Experimental Botany AS CR, Šlechtitelů 27, CZ-783 71 Olomouc, Czech Republic $1 https://orcid.org/0000000201988116
- 700 1_
- $a Perecko, Tomas $u Department of Cell Biology and Radiobiology, Institute of Biophysics of the Czech Academy of Sciences, Kralovopolska 135, 612 00 Brno, Czech Republic $1 https://orcid.org/0000000342784088 $7 mub20221141369
- 773 0_
- $w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 68, č. 11 (2025), s. 12172-12184
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40419458 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250708 $b ABA008
- 991 __
- $a 20250731090914 $b ABA008
- 999 __
- $a ok $b bmc $g 2366278 $s 1252449
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 68 $c 11 $d 12172-12184 $e 20250526 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
- LZP __
- $a Pubmed-20250708